Effect of an educational program (PEGASE) on cardiovascular risk in hypercholesterolaemic patients

Cardiovascular Drugs and Therapy

Volumn 22, Issue 6, 2008, Pages 495-505

  Bruckert, Eric ^a   Giral, Philippe ^a   Paillard, François ^b   Ferrières, Jean ^c   Schlienger, Jean Louis ^d   Renucci, Jean François ^e   Abdennbi, Kamel ^f   Durack, Isabelle ^g   Chadarevian, Rita ^h  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b RENNES UNIVERSITY HOSPITAL   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^f CCN   (France)

^g Edusanté   (France)

^h ASTRAZENECA   (United Kingdom)

Author keywords

Cardiovascular prevention; Cholesterol; Educational program; Framingham score; PEGASE

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DEMOGRAPHY; DIABETES MELLITUS; DIET; EDUCATION PROGRAM; FEMALE; FRAMINGHAM SCORE; FRANCE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRIMARY PREVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; RISK REDUCTION; SCORING SYSTEM; SECONDARY PREVENTION; SMOKING; STATISTICAL ANALYSIS;

AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; EDUCATION, MEDICAL, CONTINUING; FEMALE; FOOD HABITS; FRANCE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT EDUCATION AS TOPIC; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PROFESSIONAL-PATIENT RELATIONS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TIME FACTORS; TOTAL QUALITY MANAGEMENT;

EID: 55949096414     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-008-6137-4     Document Type: Article

References (58)

1. Murray CJL, Lopez AD (eds). The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Boston: Harvard School of Public Health; 1996
2. World Health Organization cardiovascular disease fact sheet [online]. URL: http://www.who.int/cardiovascular_diseases/en/. Accessed 19 December 2007.
3. JS Forrester CN Merz TL Bush JN Cohn DB Hunninghake S Parthasarathy 1996 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 4. Efficacy of risk factor management J Am Coll Cardiol 27 991 1006
4. T Kita 2004 Coronary heart disease risk in Japan-an East/West divide Eur Heart J. 6 A8 11
5. R Gupta M Sarna J Thanvi P Rastogi V Kaul VP Gupta 2004 High prevalence of multiple coronary risk factors in Punjabi Bhatia community: Jaipur Heart Watch-3 Indian Heart J. 56 646 52
6. Scandinavian Simvastatin Survival Study Group 1994 Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1383 9
7. J Shepherd SM Cobbe I Ford CG Isles AR Lorimer PW MacFarlane 1995 Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med. 333 1301 7
8. S Yusuf S Hawken S Ounpuu T Dans A Avezum F Lanas 2004 Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet. 364 937 52
9. EUROASPIRE Study Group. EUROASPIRE 1997 A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results Eur Heart J. 18 1569 82 Erratum in: Eur Heart J 1998; 19:356-357
10. EUROASPIRE II Study Group 2001 Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme Eur Heart J. 22 554 72
11. The Clinical Quality Improvement Network (CQIN) Investigators 1995 Low incidence of assessment and modification of risk factors in acute care patients at high risk for cardiovascular events, particularly among females and the elderly Am J Cardiol. 76 570 3
12. EF Ellerbeck SF Jencks MJ Radford TF Kresowik AS Craig JA Gold 1995 Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project JAMA. 273 1509 14
13. TJ McLaughlin SB Soumerai DJ Willison JH Gurwitz C Borbas E Guadagnoli 1996 Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly Arch Intern Med. 156 799 805 Erratum in: Arch Intern Med 1996; 156:1920
14. JP Frolkis SJ Zyzanski JM Schwartz PS Suhan 1998 Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines Circulation. 98 851 5
15. EUROASPIRE I and II Group 2001 European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries Lancet. 357 995 1001
16. CA Sueta M Chowdhury SJ Boccuzzi SC Smith Jr CM Alexander A Londhe 1999 Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease Am J Cardiol. 83 1303 7 Erratum in: Am J Cardiol 1999; 84:1143
17. B Kopjar AE Sales SL Pineros H Sun YF Li AN Hedeen 2003 Adherence with statin therapy in secondary prevention of coronary heart disease in veterans administration male population Am J Cardiol. 92 1106 8
18. WC House L Pendleton L Parker 1986 Patients' versus physicians' attributions of reasons for diabetic patients' noncompliance with diet Diabetes Care. 9 434
19. WF Riesen R Darioli G Noll 2004 Lipid-lowering therapy: strategies for improving compliance Curr Med Res Opin. 20 165 73
20. G De Backer E Ambrosioni K Borch-Johnsen C Brotons R Cifkova J Dallongeville 2003 European Society of Cardiology Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts) Eur J Cardiovasc Prev Rehabil 10 S1 10
21. TA Pearson PE McBride NH Miller SC Smith 1996 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 8. Organization of preventive cardiology service J Am Coll Cardiol. 27 1039 47
22. CC Revell SA Schroeder 2005 Simplicity matters: using system-level changes to encourage clinician intervention in helping tobacco users quit Nicotine Tob Res. 7 Suppl 1 S67 9
23. S Ebrahim G Davey Smith 1997 Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease BMJ. 314 1666 74
24. J Ferrieres I Durack-Bown P Giral R Chadarevian A Benkritly E Bruckert 2006 Patient education and patient at risk. A new approach in cardiology Ann Cardiol Angeiol (Paris). 55 27 31
25. JO Prochaska CC Di Clemente 1992 Stages of change in the modification of problem behaviors Prog Behav Modif. 28 183 218
26. WHO Working Group Report. Therapeutic Patient Education: Continuing education programmes for healthcare providers in the field of prevention of chronic diseases. Copenhagen, Denmark: WHO-Europe; 1998.
27. I Durack-Bown I Giral JF d'Ivernois C Bazin R Chadarevian A Benkritly 2003 Patients' and physicians' perceptions and experience of hypercholesterolaemia: a qualitative study Br J Gen Pract. 53 851 7
28. JE Brazier R Harper NM Jones A O'Cathain KJ Thomas T Usherwood 1992 Validating the SF-36 health survey questionnaire: new outcome measure for primary care BMJ. 305 160 4
29. A Norman R Bellocco A Bergstrom A Wolk 2001 Validity and reproducibility of self-reported total physical activity-differences by relative weight Int J Obes Relat Metab Disord. 25 682 8
30. B Laviolle C Froger-Bompas P Guilloc A Sevestred C Letelliere M Pouchard 2005 Relative validity and reproducibility of a 14-item semi-quantitative food frequency questionnaire for cardiovascular prevention Eur J Cardiovasc Prev Rehabil. 12 587 95
31. KM Anderson PWF Wilson PM Odell WB Kannel 1991 An updated coronary risk profile: a statement for health professionals Circulation. 83 357 63
32. LD Nguyen Phong Chau B Cazelles P Segond PCV-Metra Group 1994 Estimation of CHD risk in a French working population using a modified Framingham model. J Clin Epidemiol. 47 1353 64
33. TF Thomsen D McGee M Davidsen T Jorgensen 2002 A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study Int J Epidemiol. 31 817 22
34. RB D'Agostino Sr S Grundy LM Sullivan P Wilson CHD Risk Prediction Group 2001 2001 Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation JAMA. 286 180 7
35. P Brindle J Emberson F Lampe M Walker P Whincup T Fahey 2003 Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study BMJ. 327 1267
36. JP Empana P Ducimetiere D Arveiler J Ferrieres A Evans JB Ruidavets 2003 Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study Eur Heart J. 24 1903 11
37. LA Bazzano J He LG Ogden C Loria S Vupputuri L Myers 2001 Legume consumption and risk of coronary heart disease in US men and women. NHANES I epidemiologic follow-up study Arch Intern Med. 161 2573 8
38. I Ellingsen I Hjermann M Abdelnoor EM Hjerkinn S Tonstad 2003 Dietary and antismoking advice and ischemic heart disease mortality in men with normal or high fasting triacylglycerol concentrations: a 23-y follow-up study Am J Clin Nutr. 78 935 40
39. JH Lichtman J Amatruda S Yaari S Cheng GL Smith JA Mattera 2004 Clinical trial of an educational intervention to achieve recommended cholesterol levels in patients with coronary artery disease Am Heart J. 147 522 8
40. A Sartorio CL Lafortuna PG Marinone A Tavani C La Vecchia C Bosetti 2003 Short-term effects of two integrated, non-pharmacological body weight reduction programs on coronary heart disease risk factors in young obese patients Diabetes Nutr Metab. 16 262 5
41. LE Burke J Dunbar-Jacob S Sereika CK Ewart 2003 Development and testing of the Cholesterol-Lowering Diet Self-Efficacy Scale Eur J Cardiovasc Nurs. 2 265 73
42. PD Mullen DA Mains RA Velez 1992 Meta-Analysis of controlled trials of Cardiac Patient Education Patient Educ Couns. 19 143 62
43. RH Mehta CK Montoye M Gallogly P Baker A Blount J Faul 2002 Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative JAMA. 287 1269 76
44. GC Fonarow A Gawlinski 2000 Rationale and design of the Cardiac Hospitalization Atherosclerosis Management Program at the University of California Los Angeles Am J Cardiol. 85 10A 7A
45. RT Tsuyuki JA Johnson KK Teo ML Ackman RS Biggs A Cave 1999 Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk Ann Pharmacother. 33 910 9
46. V Reid E Barnes L Daly 2001 Information sessions for outpatients referred to a hospital Nutrition and Dietetic Service for cholesterol lowering advice J Hum Nutr Diet. 15 281 6
47. AS Ammerman TC Keyserling JR Atwood JD Hosking H Zayed C Krasny 2003 A randomized controlled trial of a public health nurse directed treatment program for rural patients with high blood cholesterol Prev Med. 36 340 51
48. JG Robinson C Conroy WJ Wickemeyer 2000 A novel telephone-based system for management of secondary prevention to a low-density lipoprotein cholesterol ≤100 mg/dl Am J Cardiol. 85 305 8
49. RM Guthrie 2001 The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program Clin Ther. 23 970 80
50. E Soignantes 1998 Photolanguage, a group psychotherapy Soins Psychiatr. 196 16 20
51. Baptiste A, Belisle C. Photolangage®. Prévention et Santé (dossier: 48 photos). Paris: Les éditions d'Organisation; 1994. p. 91-122.
52. G Davey Smith F Song TA Sheldon 1993 Cholesterol lowering and mortality: the importance of considering initial level of risk BMJ. 306 1367 73
53. JA Simon TP Carmody ES Hudes E Snyder J Murray JA Simon 2003 Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers treated with transdermal nicotine replacement: a randomized trial Am J Med. 114 555 62
54. L Ranney C Melvin L Lux E McClain KN Lohr 2006 Systematic review: smoking cessation intervention strategies for adults and adults in special populations Ann Intern Med. 145 845 56
55. SM Mohiuddin AN Mooss CB Hunter TL Grollmes DA Cloutier DE Hilleman 2007 Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease Chest. 131 446 52
56. M Sohn NA Stotts N Benowitz D Christopherson KS Kim YS Jang 2007 Beliefs about health, smoking, and future smoking cessation among South Korean men hospitalized for cardiovascular disease Heart Lung. 36 339 47
57. The Multiple Risk Factor Intervention Trial Research Group 1990 Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial JAMA. 263 1795 801 Erratum in: JAMA 1990; 263:3151
58. PG O'Malley C Kowalczyk J Bindeman AJ Taylor 2006 The impact of cardiovascular risk factor case management on the metabolic syndrome in a primary prevention population: results from a randomized controlled trial J Cardiometab Syndr. 1 6 12